Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans

BACKGROUND: The current strategy for the elimination of onchocerciasis is based on annual or bi-annual mass drug administration with ivermectin. However, due to several limiting factors there is a growing concern that elimination of onchocerciasis cannot be achieved solely through the current strate...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Parakkal Jovvian, Hess, Jessica A., Jain, Sonia, Patton, John B., Zhan, Tingting, Tricoche, Nancy, Zhan, Bin, Bottazzi, Maria Elena, Hotez, Peter J., Abraham, David, Lustigman, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762197/
https://www.ncbi.nlm.nih.gov/pubmed/31525197
http://dx.doi.org/10.1371/journal.pntd.0007730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762197/
https://www.ncbi.nlm.nih.gov/pubmed/31525197
http://dx.doi.org/10.1371/journal.pntd.0007730

Ejemplares similares